Home › Funds › Jones Hill Capital LP › IMCR
Jones Hill Capital LP position in IMCR
IMMUNOCORE HLDGS PLC · Health Care
Jones Hill Capital LP reported holding 384,278 shares of IMCR (IMMUNOCORE HLDGS PLC) in its Q3 2026 13F filing — a position valued at US$11.6M, representing 1.98% of its reported portfolio and ranking #18 among its reported holdings. Jones Hill Capital LP has disclosed IMCR holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Jones Hill Capital LP's IMCR position evolved
Jones Hill Capital LP first disclosed a stake in IMCR in Q2 2026 at 512,856 shares (US$16.3M). Across 2 filings, Jones Hill Capital LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 384,278 shares valued at US$11.6M — a reduction of -128,578 shares quarter over quarter.. Notable position changes include a 25% trim in Q3 2026 (shares fell 1% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 512.86K | $16.28M | New |
| Q3 2026 | 384.28K | $11.64M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IMCR and 13F data
IMCR (IMMUNOCORE HLDGS PLC) is a Health Care company. 29 other funds we track also report a position in IMCR — the largest reported positions include RTW INVESTMENTS, LP (US$154.6M), Bellevue Group AG (US$88.5M), TANG CAPITAL MANAGEMENT LLC (US$84.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IMCR
- RTW INVESTMENTS, LP 4.87M sh · $154.62M · Q2 2026
- Bellevue Group AG 2.79M sh · $88.53M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 2.65M sh · $84.12M · Q2 2026
- Vestal Point Capital, LP 1.80M sh · $57.15M · Q2 2026
- ARMISTICE CAPITAL, LLC 1.43M sh · $45.34M · Q2 2026
- Caligan Partners LP 1.38M sh · $43.86M · Q2 2026
- Kynam Capital Management, LP 1.38M sh · $43.66M · Q2 2026
- BVF INC/IL 1.29M sh · $41.10M · Q2 2026
- Trails Edge Capital Partners, LP 1.06M sh · $33.76M · Q2 2026
- Logos Global Management LP 600.00K sh · $19.05M · Q2 2026
- Frazier Life Sciences Management, L.P. 484.78K sh · $15.39M · Q2 2026
More on Jones Hill Capital LP
FAQ
How long has Jones Hill Capital LP held IMCR?
Jones Hill Capital LP has disclosed IMCR holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Jones Hill Capital LP's current position in IMCR?
As of Q3 2026, Jones Hill Capital LP holds 384.28K shares of IMCR (IMMUNOCORE HLDGS PLC), valued at $11.64M, representing 1.98% of its reported portfolio and ranking #18.
Has Jones Hill Capital LP been buying or selling IMCR?
In the latest 13F filing (Q3 2026), Jones Hill Capital LP reduced its position in IMCR.
Which other funds hold IMCR?
Other major institutional holders of IMCR include RTW INVESTMENTS, LP, Bellevue Group AG, TANG CAPITAL MANAGEMENT LLC, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.